Pacer Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.3M Buy
898,154
+819,345
+1,040% +$66.1M 0.18% 138
2026
Q1
$6.83M Sell
78,809
-36,684
-32% -$3.51M 0.02% 535
2025
Q4
$11.1M Sell
115,493
-474,700
-80% -$46.1M 0.03% 467
2025
Q3
$56.2M Sell
590,193
-6,285
-1% -$578K 0.14% 158
2025
Q2
$52M Buy
596,478
+517,194
+652% +$43.9M 0.13% 169
2025
Q1
$7.12M Sell
79,284
-42,272
-35% -$3.78M 0.02% 549
2024
Q4
$9.71M Sell
121,556
-20,812
-15% -$1.8M 0.02% 467
2024
Q3
$12.8M Buy
142,368
+18,171
+15% +$1.53M 0.03% 409
2024
Q2
$9.78M Buy
124,197
+33,959
+38% +$2.78M 0.02% 436
2024
Q1
$7.86M Buy
90,238
+2,402
+3% +$205K 0.02% 484
2023
Q4
$7.24M Sell
87,836
-2,182
-2% -$166K 0.02% 480
2023
Q3
$7.05M Sell
90,018
-13,710
-13% -$1.15M 0.03% 388
2023
Q2
$9.14M Buy
103,728
+4,691
+5% +$404K 0.04% 405
2023
Q1
$7.98M Sell
99,037
-34,146
-26% -$2.78M 0.03% 467
2022
Q4
$10.4M Buy
133,183
+123,803
+1,320% +$10M 0.05% 328
2022
Q3
$757K Sell
9,380
-72,933
-89% -$6.55M 0.01% 621
2022
Q2
$7.39M Buy
82,313
+13,207
+19% +$1.34M 0.05% 317
2022
Q1
$7.67M Sell
69,106
-1,378
-2% -$146K 0.06% 318
2021
Q4
$7.29M Sell
70,484
-22,882
-25% -$2.65M 0.07% 242
2021
Q3
$11.7M Buy
93,366
+17,680
+23% +$2.29M 0.15% 168
2021
Q2
$9.39M Buy
75,686
+1,766
+2% +$222K 0.13% 152
2021
Q1
$8.73M Sell
73,920
-9,372
-11% -$1.1M 0.15% 101
2020
Q4
$9.76M Buy
+83,292
New +$9.17M 0.18% 82
2018
Q3
Sell
-63,101
Closed -$5.4M 1229
2018
Q2
$5.4M Buy
+63,101
New +$5.27M 0.24% 59
2013
Q4
$399K Buy
+5,522
New +$313K 0.1% 277

Other funds holding MDT

Pacer Advisors's MDT Position: Q2 2026 in Review

Pacer Advisors increased its Medtronic (MDT) stake by 1,040% in Q2 2026, buying an estimated $66.1M and bringing the position to 898,154 shares worth $70.3M. The position accounts for 0.18% of the portfolio, ranked #138.

Pacer Advisors first reported a position in MDT in Q4 2013 and has held it in 25 quarters since. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pacer Advisors held 898,154 shares of Medtronic worth $70.3M as of Q2 2026.
  • Pacer Advisors bought 819,345 Medtronic shares in Q2 2026, an estimated $66.1M.
  • Medtronic made up 0.18% of Pacer Advisors's portfolio in Q2 2026, its #138 holding.
  • Pacer Advisors first reported a position in Medtronic in Q4 2013 and has held it in 25 quarters since.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.